Seizure disorders in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 31, Issue 2, 2004, Pages 373-384

  Pschirrer, E Rebecca ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; FOLIC ACID; FRESH FROZEN PLASMA; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROTHROMBIN; TRIMETHADIONE; VALPROIC ACID; VITAMIN K GROUP;

ALOPECIA; BLEEDING; BLOOD CLOTTING DISORDER; CLEFT FACE; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; COUNSELING; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; DISTAL DIGITAL HYPOPLASIA; DRUG BLOOD LEVEL; DRUG INDICATION; EAR MALFORMATION; EEG ABNORMALITY; EPICANTHUS; FACE DYSMORPHIA; FACE MALFORMATION; FETAL ANTICONVULSANT SYNDROME; FETAL HYDANTOIN SYNDROME; FETUS MALFORMATION; GROWTH RETARDATION; HAIR DISEASE; HEALTH; HEALTH CARE COST; HEART DISEASE; HUMAN; HYPERTELORISM; INCIDENCE; INTELLIGENCE QUOTIENT; LIP MALFORMATION; MATERNAL CARE; MENTAL DEFICIENCY; METABOLIC DISORDER; METHEMOGLOBINEMIA; MICROCEPHALY; MONOTHERAPY; MOUTH MALFORMATION; NAIL HYPOPLASIA; NERVE CELL; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; NOSE MALFORMATION; POLYPHARMACY; PREGNANCY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SUCKING; SUPPLEMENTATION; SYNDROME; TERATOGENESIS; THROMBOCYTOPENIC PURPURA; UNITED STATES; UROGENITAL TRACT MALFORMATION;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 2942536520     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2004.03.003     Document Type: Review

References (77)

1. Eller DP, Patterson CA, Webb GW. Maternal and fetal implications of anticonvulsive therapy during pregnancy. Obstet Gynecol Clinics 1997;24:523-34.
2. Quality Standards Subcommittee of the American Academy of Neurology. Management issues for women with epilepsy (summary statement). Neurology 1998;51:944-8.
3. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000;41:342-51.
4. Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav 2003;4:S2-12.
5. Pack AM, Morrell MJ. Treatment of women with epilepsy. Semin Neurol 2002;22:289-98.
6. McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 41:559-79.
7. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975;16:99-110.
8. Schmidt D, Canger R, Avanzini G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 1983;46:751-5.
9. Yerby MS. Pregnancy and epilepsy. Epilepsia 1991;32(Suppl 6):S51
10. Tanganelli P, Regesta G. Epilepsy, pregnancy and major birth anomalies: an Italian prospective, controlled study. Neurology 1992;42:89-93.
11. American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. ACOG Educ Bull 1996;231. Int J Gynaecol Obstet 1997;56(3):279-86.
12. American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. ACOG Educ Bull 1996;231. Int J Gynaecol Obstet 1997;56(3):279-86.
13. McAuley JW, Anderson GD. Treatement of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 2002;41:559.
14. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-90.
15. Brodie MJ, Dichter M.A. Antiepileptic drugs. NEJM 1996;334:168-75.
16. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA 2004;291:605-14.
17. Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 2003;25:347-63.
18. Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 1998;51:904-6.
19. Morrell M. Guidelines for the care of women with epilepsy. Neurology 1998;51:S21-7.
20. Arpino C, Brescianini S, Robert E, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000;41:1436-43.
21. Samren EB, van Duijin CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-90.
22. Yerby MS, Leavitt A, Erickson DM, et al. Antiepileptics and the development of congenital anomalies. Neurology 1992;42(Suppl 5):132-40.
23. Hernandez-Diaz S, Werler M, Walker A. Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 2000;343:1608-14.
24. Annegers JF, Elveback LR, Hauser WA, et al. Do anticonvulsants have a teratogenic effect? Arch Neurol 1974;31:364-73.
25. Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9.
26. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-7.
27. Omtzigt JGC, Los FJ, Grobee DE, et al. The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(Suppl 5):119-25.
28. Mawer G, Clayton-Smith J, Coyle H, et al. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium-valproate. Seizure 2002;11:512-8.
29. Delgado-Escueta A, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42(Suppl 5):149-60.
30. Zackai E, Mellman W, Neiderer B, et al. The fetal trimethadione syndrome. J Pediatr 1975;87:280-4.
31. Hanson JW, Myrianthopoulos NC, Harvey MAS, et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976;89:662-8.
32. Malm H, Kajantie E, Kivirikko S, et al. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology 2002;59:630-3.
33. A North American Registry for Epilepsy and Pregnancy. A unique public/private partnership of health surveillance. Epilepsia 1998;39:793-8.
34. Montouris G. Gabapentin exposure in human pregnancy: results from the gabapentin pregnancy registry. Epilepsy Behav 2003;4:310-7.
35. Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 2003;4:447-8.
36. Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988;29:459-67.
37. Koch S, Lösche G, Jäger-Roman E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(Suppl 5):83-8.
38. Lindhout D, Omtzigt JGC. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia 1994;35:S19-28.
39. Pennell PB. The importance of monotherapy in pregnancy. Neurology 2003;60:S31-8.
40. Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6.
41. Holmes LB, Rosenberger PB, Harvey EA, et al. Intelligence and physical features of children of women with epilepsy. Teratology 2000;61:196-200.
42. Koch S, Titze K, Zimmermann RB, et al. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999;40:1237-43.
43. Cornelissen M, Steegers-Teunissen R, Kolle L, et al. Increasing incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. AmJ Obstet Gynecol 1993;168:923-8.
44. Cornelissen M, Steegers-Teunissen R, Kolle L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168:884-8.
45. Deblay MF, Vert P, André M, et al. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother [letter]. Lancet 1982;1:1247.
46. American Academy of Pediatrics. Controversies concerning vitamin K and the newborn. Policy statement. Pediatrics 2003;112:191-2.
47. Bleyer WA, Skinner AL. Fatal neonatal hemorrhage after maternal anticonvulsant therapy. JAMA 1976;235:626.
48. Aminoff MJ. Neurologic disorders. In: Creasy RK, Resnik R, editors. Maternal-fetal medicine. 4th edition. Philadelphia: WB Saunders; 1999. p. 1091-2019.
49. Grimes DA. Unplanned pregnancies in the US. Obstet Gynecol 1986;67:438-42.
50. Seale CG, Morrell MJ, Nelson L, et al. Analysis of prenatal and gestational care given to women with epilepsy. Neurology 1998;51:1039-45.
51. Crawford P, Lee P. Gender difference in management of epilepsy - what women are hearing. Seizure 1999;8:135-9.
52. Crawford P, Hudson S. Understanding the information needs of women with epilepsy at different lifestages: results of the "Ideal World" survey. Seizure 2003;12:502-7.
53. Eller DP, Patterson CA, Webb GW. Maternal and fetal implications of anticonvulsive therapy during pregnancy. Obstet Gynecol Clin North Am 1997;24:523-34.
54. Gilmore J, Pennell PB, Stern BJ. Medication use during pregnancy for neurologic conditions. Neurol Clin North Am 1998;16:189-206.
55. Nulman I, Scolnik D, Chitayat D, et al. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 1997;68:18-24.
56. Koch S, Lösche G, Jäger-Roman E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(Suppl 5):83-8.
57. Annegers JF, Hauser WA, Elveback LR, et al. Seizure disorders in offspring of parents with a history of seizures - a maternal-paternal difference? Epilepsia 1976;17:1-9.
58. Strauss RG, Bernstein R. Folic acid and dilantin antagonism in pregnancy. Obstet Gynecol 1974;44:345-8.
59. Dam M, Christiansen J, Munck O, et al. Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet 1979;4:53-62.
60. Eadie MJ, Lander CM, Tyrer JH. Plasma drug level monitoring in pregnancy. Clin Pharmacokinet 1977;2:427-36.
61. Mauguiere F, Quoex C, Bello S. Epileptogenic properties of folic acid and N5 methyltetrahydrofolate in cat. Epilepsia 1975;16:535-41.
62. MMWR. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. 1992;41:1-7.
63. Locksmith GJ, Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 1998;91:1027-34.
64. American College of Obstetricians and Gynecologists. Maternal serum screening. ACOG Educ Bull 1996;(228). Int J Gynaecol Obstet 1996;55:299-308.
65. American College of Obstetricians and Gynecologists. Maternal serum screening. ACOG Educ Bull 1996;(228). Int J Gynaecol Obstet 1996;55:299-308.
66. Moore KL. The developing human: clinically oriented embryology. 4th edition. Philadelphia: W.B. Saunders Company; 1988.
67. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 2003;44:33-40.
68. Bjerkedal T, Bahna SL. The occurrence and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 1973;52:245-8.
69. Burnett CWF. A survey of the relation between epilepsy and pregnancy. J Obstet Gynaecol Br Emp 1946;53:539.
70. Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in children. Neurology 1982;32:1247-54.
71. Orringer CE, Eustace JC, Wunsch CD, et al. Natural history of lactic acidosis after grand mal seizures. N Engl J Med 1977;297:796-9.
72. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985;152:499-504.
73. Kallen B. A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand 1986;73:253-9.
74. Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology 1992;42(Suppl 5):8.
75. Knott C, Reynolds F, Clayden G. Infantile spasms on weaning from breastmilk containing anticonvulsants. Lancet 1987;2:272-3.
76. Ito S, Moretti M, Liau M, et al. Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Ostet Gynecol 1995;172:881-6.
77. Bar-Oz B, Nulman I, Koren G, et al. Anticonvulsants and breastfeeding: a critical review. Pediatr Drugs 2000;2:113-26.